Doubling survival in pancreatic cancer, a long-fought rare disease approval, a massive IPO and ambitious biotech ...
At the start of Ben Lerner's startling new novel "Transcription," a man sits on a train trying to read and failing because he ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果